Condition
Hemophagocytic Lymphohistiocytoses clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Hemophagocytic Lymphohistiocytoses clinical trials that are recruiting, at sites in 10 countries (most in United States (3), Egypt (1), South Korea (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 10Countries
Newest Hemophagocytic Lymphohistiocytoses clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| National Egyptian HLH Registry for pediatric patients | — | Cairo and 1 other locations | Recruiting | Sep 2, 2026 |
| Using ruxolitinib with a modified HLH-94 regimen to treat hemophagocytic lymphohistiocytosis. | Phase 2 | Irvine, California and 3 other locations | Recruiting | Dec 7, 2023 |
| Understanding treatment outcomes in lymphoma-related hemophagocytic lymphohistiocytosis | — | Birmingham, Alabama | Recruiting | Jun 12, 2023 |
| Validation of the OHI Index for Hematologic Malignancies | — | Kfar Saba and 1 other locations | Recruiting | May 31, 2023 |
| Registry for patients with Hemophagocytic Lymphohistiocytosis | — | Cincinnati, Ohio | Recruiting | Mar 14, 2022 |
| Registry for monitoring CytoSorb device use in critically ill patients | — | Klagenfurt and 27 other locations | Recruiting | Dec 6, 2021 |
| Observational study on adult hemophagocytic lymphohistiocytosis | — | Seoul | Recruiting | Apr 17, 2017 |
All recruiting trials (7)
-
National Egyptian HLH Registry for pediatric patients
A national HLH registry is being created in Egypt to collect information about pediatric HLH patients to improve understanding and care.
-
Using ruxolitinib with a modified HLH-94 regimen to treat hemophagocytic lymphohistiocytosis.
This study is testing if a new combination of ruxolitinib and a modified treatment plan can help adults newly diagnosed with hemophagocytic lymphohistiocytosis feel better and live longer.
-
Understanding treatment outcomes in lymphoma-related hemophagocytic lymphohistiocytosis
This study looks at how people with lymphoma who develop a serious condition called hemophagocytic lymphohistiocytosis are treated and what the outcomes are, to find better ways to help them survive.
-
Validation of the OHI Index for Hematologic Malignancies
This study is testing a new index to see if it can help doctors better understand and predict outcomes for patients with blood cancers who might develop a serious condition called HLH.
-
Registry for patients with Hemophagocytic Lymphohistiocytosis
This study is collecting information from patients with Hemophagocytic Lymphohistiocytosis to better understand the condition and improve future treatments.
-
Registry for monitoring CytoSorb device use in critically ill patients
This study is collecting information on how the CytoSorb device helps critically ill patients to improve care for conditions like septic shock and acute respiratory distress syndrome.
-
Observational study on adult hemophagocytic lymphohistiocytosis
This study is looking at adults with hemophagocytic lymphohistiocytosis to learn more about their symptoms and how they respond to treatments like immunosuppressive therapy or chemotherapy.
Related topics
Quick answers
How many Hemophagocytic Lymphohistiocytoses clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (3 trials), Egypt (1 trial), South Korea (1 trial), Israel (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.